CD19 and acute lymphoblastic leukemia: They observed that the presence of a IgG1-CH2CH3 spacer in the CD19-targeted mRNA CAR construct inhibited the cytotoxic efficacy of the reprogrammed CAR T cells in a mouse Nalm-6–ALL xenograft model.